exendin-4 based dual GLP-1/glucagon receptor agonist
(2~{S})-2-[[(4~{S})-4-(hexadecanoylamino)-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]pentanedioic acid
Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations.
structures with the least restraint violations
5 mg/mL Peptide 12, trifluoroethanol/water
binding site for Ligand residues AIB A 34 through LYS A 35 bound to SER A 33